Nutex Health (NUTX) Cash & Current Investments (2010 - 2026)

Nutex Health has disclosed Cash & Current Investments across 17 years of filings, most recently posting $210.6 million for Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $210.6 million, up 140.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $210.6 million (up 140.26% YoY), and the FY2025 annual result was $185.9 million, up 326.5% from the prior year.
• Cash & Current Investments came in at $210.6 million for Q1 2026 at Nutex Health, up from $185.9 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $210.6 million in Q1 2026 to a low of $3.3 million in Q1 2022.
• The 5-year median for Cash & Current Investments is $40.8 million (2024), against an average of $67.3 million.
• Across the five-year window, Cash & Current Investments slumped 82.64% in 2022 and soared 909.53% in 2023, its largest moves.
• Nutex Health's Cash & Current Investments stood at $34.3 million in 2022, then slumped by 35.77% to $22.0 million in 2023, then surged by 98.08% to $43.6 million in 2024, then surged by 326.5% to $185.9 million in 2025, then grew by 13.33% to $210.6 million in 2026.
• The last three Cash & Current Investments figures came in at $210.6 million (Q1 2026), $185.9 million (Q4 2025), and $166.0 million (Q3 2025), per Business Quant data.